Obinutuzumab Therapy in Patients With Marginal Zone and Mantle Cell Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.74_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Marginal Zone B-Cell Lymphoma

English

Peripheral T-Cell Lymphoma Mimicking Marginal Zone B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2002English

Splenic Marginal Zone Lymphoma

2020English

Obinutuzumab Plus Ibrutinib in Relapse/Refractory Mantle Cell Lymphoma Patients: First Results of the Oasis Phase I Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Copanlisib Treatment of Patients With Relapsed or Refractory Marginal Zone Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Biclonal Splenic Marginal Zone Lymphoma With T Cell-Rich Background and Aggressive Transformation to Large Cell Lymphoma

Journal of Hematopathology
Forensic MedicinePathologyHematologyHistology
2019English

Impact of Initial Therapy on Survival in Splenic Marginal Zone Lymphoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Extranodal Marginal Zone B Cell Lymphoma of the Lung

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy